Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Sees Significant Decrease in Short Interest

Alpha Tau Medical Ltd. (NASDAQ:DRTSW) was the recipient of a significant decline in short interest in June. As of June 15th, there was short interest totaling 2,774 shares, a decline of 82.5% from the May 31st total of 15,871 shares. Based on an average daily volume of 38,408 shares, the short-interest ratio is presently 0.1 days.

Alpha Tau Medical Price Performance

DRTSW stock opened at $2.29 on Friday. The company’s 50-day moving average is $1.81 and its 200-day moving average is $1.17. Alpha Tau Medical has a 1 year low of $0.20 and a 1 year high of $2.99.

Alpha Tau Medical Company Profile

Alpha Tau Medical Ltd. is a clinical-stage medical technology company focused on the development of alpha-emitting radiation therapy for the treatment of solid tumor cancers. The company’s proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) platform leverages the short-range, high-energy alpha particles emitted by radium-224 to penetrate tumor tissues more effectively than conventional external-beam radiation. By implanting thin, needle-like sources directly into a tumor, Alpha DaRT delivers concentrated doses of radiation to malignant cells while sparing surrounding healthy tissue.

The Alpha DaRT technology is designed to enhance local tumor control in a variety of solid tumors, including head and neck, breast, skin, and pancreatic cancers.